New Insight Into Platelet Activation and Thrombosis: Is There a Role for IL-37?

HomeCirculation ResearchVol. 132, No. 9New Insight Into Platelet Activation and Thrombosis: Is There a Role for IL-37? No AccessEditorialRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessEditorialRequest AccessFull TextNew Insight Into Platelet Activation and Thrombosis: Is There a Role for IL-37? Pasquale Pignatelli, Francesco Violi and Vittoria Cammisotto Pasquale PignatelliPasquale Pignatelli Correspondence to: Pasquale Pignatelli, MD, Department of Clinical Internal, Anaesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Viale del Policlinico 155, Rome 00161, Italy. Email E-mail Address: [email protected] https://orcid.org/0000-0002-2265-7455 Department of Clinical Internal, Anaesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Italy (P.P., F.V., V.C.). Mediterranea Cardiocentro-Napoli, Italy (P.P., F.V.). Search for more papers by this author , Francesco VioliFrancesco Violi https://orcid.org/0000-0002-6610-7068 Department of Clinical Internal, Anaesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Italy (P.P., F.V., V.C.). Mediterranea Cardiocentro-Napoli, Italy (P.P., F.V.). Search for more papers by this author and Vittoria CammisottoVittoria Cammisotto Department of Clinical Internal, Anaesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Italy (P.P., F.V., V.C.). Search for more papers by this author Originally published27 Apr 2023https://doi.org/10.1161/CIRCRESAHA.123.322780Circulation Research. 2023;132:1107–1109This article is a commentary on the followingIL-37 Attenuates Platelet Activation and Thrombosis Through IL-1R8 PathwayFootnotesFor Sources of Funding and Disclosures, see page 1109.The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.Correspondence to: Pasquale Pignatelli, MD, Department of Clinical Internal, Anaesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Viale del Policlinico 155, Rome 00161, Italy. Email pasquale.[email protected].itReferences1. Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S. Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease.Circ Res. 2016; 118:535–546. doi: 10.1161/CIRCRESAHA.115.307611LinkGoogle Scholar2. Langer HF, Gawaz M. Platelet-vessel wall interactions in atherosclerotic disease.Thromb Haemost. 2008; 99:480–486. doi: 10.1160/TH07-11-0685CrossrefMedlineGoogle Scholar3. Ruggeri ZM. Platelets in atherothrombosis.Nat Med. 2002; 8:1227–1234. doi: 10.1038/nm1102-1227CrossrefMedlineGoogle Scholar4. Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA. IL-37 is a fundamental inhibitor of innate immunity.Nat Immunol. 2010; 11:1014–1022. doi: 10.1038/ni.1944CrossrefMedlineGoogle Scholar5. Charrad R, Berraies A, Hamdi B, Ammar J, Hamzaoui K, Hamzaoui A. Anti-inflammatory activity of IL-37 in asthmatic children: correlation with inflammatory cytokines TNF-alpha, IL-beta, IL-6 and IL-17A.Immunobiology. 2016; 221:182–187. doi: 10.1016/j.imbio.2015.09.009CrossrefMedlineGoogle Scholar6. Su Z, Tao X. Current understanding of IL-37 in human health and disease.Front Immunol. 2021; 12:696605. doi: 10.3389/fimmu.2021.696605CrossrefMedlineGoogle Scholar7. Zhuang X, Wu B, Li J, Shi H, Jin B, Luo X. The emerging role of interleukin-37 in cardiovascular diseases.Immun Inflamm Dis. 2017; 5:373–379. doi: 10.1002/iid3.159CrossrefMedlineGoogle Scholar8. Chen Y, Hong J, Zhong H, Zhao Y, Li J, Shen W, Luo X, Shi H, Hu L, Liu J, et al. IL-37 attenuates platelet activation and thrombosis through IL-1R8 pathway.Circ Res. 2023; 132:e134–e150. doi: 10.1161/CIRCRESAHA.122.321787LinkGoogle Scholar9. Anselmo A, Riva F, Gentile S, Soldani C, Barbagallo M, Mazzon C, Feruglio F, Polentarutti N, Somma P, Carullo P, et al. Expression and function of IL-1R8 (TIR8/SIGIRR): a regulatory member of the IL-1 receptor family in platelets.Cardiovasc Res. 2016; 111:373–384. doi: 10.1093/cvr/cvw162CrossrefMedlineGoogle Scholar10. Xu D, Wang A, Jiang F, Hu J, Zhang X. Effects of interleukin-37 on cardiac function after myocardial infarction in mice.Int J Clin Exp Pathol. 2015; 8:5247–5251.MedlineGoogle Scholar11. Liu K, Tang Q, Zhu X, Yang X. IL-37 increased in patients with acute coronary syndrome and associated with a worse clinical outcome after ST-segment elevation acute myocardial infarction.Clin Chim Acta. 2017; 468:140–144. doi: 10.1016/j.cca.2017.02.017CrossrefMedlineGoogle Scholar12. Zhang F, Zhu T, Li H, He Y, Zhang Y, Huang N, Zhang G, Li Y, Chang D, Li X. Plasma interleukin-37 is elevated in acute ischemic stroke patients and probably associated with 3-month functional prognosis.Clin Interv Aging. 2020; 15:1285–1294. doi: 10.2147/CIA.S230186CrossrefMedlineGoogle Scholar13. Shou X, Lin J, Xie C, Wang Y, Sun C. Plasma IL-37 elevated in patients with chronic heart failure and predicted major adverse cardiac events: a 1-year follow-up study.Dis Markers. 2017; 2017:9134079. doi: 10.1155/2017/9134079CrossrefMedlineGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsRelated articlesIL-37 Attenuates Platelet Activation and Thrombosis Through IL-1R8 PathwayYufei Chen, et al. Circulation Research. 2023;132:e134-e150 April 28, 2023Vol 132, Issue 9 Advertisement Article InformationMetrics © 2023 American Heart Association, Inc.https://doi.org/10.1161/CIRCRESAHA.123.322780PMID: 37104561 Originally publishedApril 27, 2023 Keywordsthrombosiscardiovascular diseasesplatelet activationEditorialinterleukinsinflammationPDF download Advertisement